Will hematopoietic stem cell transplantation cure human autoimmune diseases?

Journal of Autoimmunity

Volumn 30, Issue 3, 2008, Pages 145-150

  Marmont, Alberto M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Autoimmune diseases; Stem cell transplantation

Indexed keywords

RHEUMATOID FACTOR;

AUTOIMMUNE DISEASE; AUTOTRANSPLANTATION; CD4+ CD25+ T LYMPHOCYTE; DISEASE COURSE; DISEASE SEVERITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOMODULATION; IMMUNOREACTIVITY; MESENCHYME CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ANIMALS; AUTOIMMUNE DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 39149112225     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.12.009     Document Type: Review

References (83)

1. In: Rose N.R., and Mackay I.R. (Eds). The autoimmune diseases (2006), Elsevier, Amsterdam-Tokyo
2. Rose N.R., and Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 14 (1993) 426-428
3. Marmont A.M. Defining criteria for autoimmune diseases. Immunol Today 15 (1994) 388
4. Chatenoud L. Emerging therapies for autoimmune diseases. In: Rose N.R., and Mackay I.R. (Eds). The autoimmune diseases (2006), Elsevier, Amsterdam-Tokyo 1063-1081
5. Burt R.K., Slavin S., Burns W.H., and Marmont A.M. Induction of tolerance in autoimmune disease by hematopoietic stem cell transplantation: getting closer to a cure?. Blood 99 (2002) 768-784
6. Goodnow C.C., Sprent J., Fazekas de St Groth B., and Vinnesa C.G. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435 (2005) 590-597
7. Marmont AM. Introduction to stem cell transplantation for autoimmune diseases. Autoimmunity, in press.
8. Marmont A.M. Coincidental autoimmune disease in patients transplanted for conventional indications. Best Pract Res Clin Haematol 17 (2004) 223-232
9. In: Burt R.K., and Marmont A.M. (Eds). Stem cell therapy for autoimmune disease (2004), Landes Bioscience, Georgetown
10. In: Gratwohl A., and Tyndall A. (Eds). Stem cell transplantation for autoimmune disorders. Best Pract Res Clin Haematol 17 (2004) 199-374
11. Kapoor S., Wilson A.G., Sharrack B., Lord A., Akil M., Lingyun S., et al. Hematopoietic stem cell transplantation-an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology. Hematology 12 (2007) 179-191
12. Marmont A.M. Lupus: tinkering with haematopoietic stem cells. Lupus 10 (2001) 769-774
13. Levite M., Zinger H., Mozes I., Reisner Y., et al. Systemic lupus erythematosus-related antibody production in mice is determined by marrow derived cells. Bone Marrow Transplant 12 (1993) 179-183
14. Reininger I., Radkiewiecs T., and Kosco E. Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB × NZW) F1 pre-B cells. J Exper Med 176 (1992) 1343-1353
15. Ikehara S. Treatment of autoimmune diseases by hematopoietic bone marrow transplantation. Exp Hematol 29 (2001) 661-669
16. Ende N., Czarnesky J., and Raveche E. Effect of human cord blood transfer on survival and disease activity in MRL-Ipr mice. Clin Immunol Immunopathol 75 (1995) 190-195
17. Ikehara S. A novel strategy for allogeneic stem cell transplantation: perfusion method plus intra-bone marrow injection stem cells. Exp Hematol 31 (2003) 1142-1146
18. Ikehara S. Intra-bone marrow marrow-bone marrow transplantation. A new strategy for treatment of stem cell disorders. Ann NY Acad Sci 1051 (2005) 626-634
19. Castello S., Podestà M., Mendillo V.G., Ibatici A., Pitto A., Figari O., et al. Intra-bone marrow injection of bone marrow and cord blood cells. An alternative way of transplantation associated with a higher seeding efficiency. Exp Hematol 32 (2004) 782-787
20. Kushida T., Inaba M., Hischa H., Ichioka N., Esumi T., Ogawa R., et al. Intra-bone marrow injection of allogeneic marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 97 (2001) 3292-3299
21. Li C., He Y., Feng X., Adachi Y., Takada K., Zhang Y., et al. An innovative approach to bone marrow collection and transplantation in a patient with B-thalassemia major: collection using a perfusion method followed by intra-bone marrow injection collected bone marrow cells. Int J Hematol 85 (2007) 73-77
22. Namjou B., Kelly J.A., and Harley J.B. The genetics of lupus. In: Tsokos G.C., Gordon C., and Smolen J.S. (Eds). Systemic lupus erythematosus (2007), Mosby-Elsevier 74-86
23. Ermann J., and Fathman C.G. autoimmune diseases: genes, bugs and failed regulation. Nature Immunol 2 (2002) 759-766
24. Van Bekkum D.W. Stem cell transplantation for autoimmune disorders. Pre-clinical experiments. Best Pract Res Clin Haematol 17 (2004) 201-222
25. Ikehara S., Kawamura M., Takao F., Inaba M., Yasumizu R., Than S., et al. Organ-specific and systemic autoimmune diseases originate from defects in haematopoietic stem cells. Proc Natl Acad Sci 87 (1990) 8341-8344
26. Marmont A.M., van Lint M.T., Gualandi F., Bacigalupo A., et al. Autologous marrow stem cell transplantation for systemic lupus erythematosus of long duration. Lupus 6 (1997) 545-548
27. Loh Y., Oyama Y., Statkute L., Quigley K., Yaung K., Gonda F., et al. Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used. Blood 109 (2007) 2643-2648
28. Marmont A.M. History perspective and rationale of HSCT for autoimmune diseases. In: Burt R.K., and Marmont A.M. (Eds). Stem cell therapy for autoimmune disease. Landes Bioscience (2004) 223-233
29. Nash R.A., Mc Sweeney P., Crofford L.J., Abidi M., Chen C.-S., Godwin J.D., et al. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter study. Blood 110 (2007) 1388-1396
30. Marmont AM, Saccardi R, editors. Haematopoietic stem cell transplantation for severe autoimmune diseases. Autoimmunity, in press.
31. Dingli D., and Michor F. Successful therapy must eradicate cancer stem cells. Stem Cells 24 (2006) 2603-2610
32. Burt R.K., Marmont A.M., Oyama Y., Slavin S., Arnold R., Hiepe F., et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases. The evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum Arthritis Rheum 54 (2006) 3750-3760
33. Gratwohl A., Passweg J., Bocelli-Tyndall C., Fassas A., van Laar J.M., Farge D., et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 35 (2005) 869-879
34. Schiffenbauer J., Hahn B., Weisman M.H., and Simon L.S. Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus. Arthritis Rheum 50 (2004) 2415-2422
35. Petri M., and Brodsky R. High-dose cyclophosphamide and stem cell transplantation for refractory systemic lupus erythematosus. JAMA 295 (2006) 559-560
36. Isaacs J.D., and Thiel A. Immune reconstitution. Best Pract Res Clin Haematol 17 (2004) 345-358
37. Herrmann M.M., Gaertner S., Stadelmann C., van den Brandt R., Boscke R., Budach W., et al. Tolerance induction by bone marrow transplantation in a multiple sclerosis model. Blood 106 (2005) 875-883
38. Gualandi F., Bruno B., van Lint M.T., Lucchetti S., Uccelli A., Capello E., et al. Autologous stem cell transplantation for severe autoimmune disease. A 10-year experience. Ann NY Acad Sci 1110 (2007) 455-464
39. Muraro P., and Douek D.C. Renewing the T cell repertoire to arrest immune aggression. Trends Immunol 27 (2006) 61-67
40. Sun W., Popat V., Hutton G., Ying C., Zang C.Q., Krance R., et al. Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain 127 (2004) 996-1008
41. Brenner M.K. Haematopoietic stem cell transplantation for autoimmune disease: limits and future potential. Best Pract Res Clin Haematol 17 (2004) 359-374
42. Muraro P.A., Douek D.C., Packer A., Chung K., Guenaga F.J., Cassiani-lngoni R., et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exper Med 201 (2005) 805-816
43. De Kleer I., Vastert B., Klein M., Teklenburg G., Arkestejn G., Yung P., et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+ CD25+ immune regulatory network. Blood 107 (2006) 1696-1702
44. Dazzi F., van Laar J.M., Cope A., and Tyndall A. Cell therapy for autoimmune diseases. Arthritis Res Ther 9 (2007) 206-215
45. Griffith L.M., Pavletic S.Z., Tyndall A., Bredeson C.N., Bowen J.O., Childs R.W., et al. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Cancer Institute sponsored International Workshop. Bethesda, MD, March 12 & 13, 2005. Biol Blood Marrow Transplant 11 (2005) 862-870
46. Young N.S., Calado R.T., and Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108 (2006) 2500-2519
47. Appelbaum F.R. Hematopoietic stem cell transplantation as immunotherapy. Nat Med 411 (2000) 385-389
48. Sykes M., and Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 435 (2005) 620-626
49. Hinterberger W., Hinterberger-Fischer M., and Marmont A.M. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favourably effects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 30 (2002) 753-759
50. Marmont A.M., Gualandi F., van Lint M.T., and Bacigalupo A. Refractory Evans syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant 31 (2003) 399-401
51. Musso M., Porretto F., Crescimanno A., Polizzi V., Scalone R., et al. Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and allogeneic peripheral stem cell transplantation. Bone Marrow Transplant 33 (2004) 769-771
52. Hayden P.J., Grampe M., Lawler M., Sedor J.R., et al. use of DLI to achieve complete donor chimerism in a patient receiving systemic immunosuppression for refractory AIHA post-NST. Bone Marrow Transplant 36 (2005) 735-736
53. Marmont A.M., Dominietto A., Gualandi F., Piaggio G., van Lint M.T., Bacigalupo A., et al. Pure white cell aplasia (PWCA) relapsing after allogeneic BMT and successfully treated with nine DLI. Biol Blood Marrow Transplant 12 (2006) 987-989
54. Chakrabarti S., Handa S.K., Byron R.J., Griffiths M.J., Milligan D.W., et al. Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant?. Transplantation 72 (2001) 340-342
55. Burt R.K., Oyama Y., Verda L., Quigley K., Brush M., Yaung K., et al. Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum 50 (2004) 2466-2470
56. van Wijmeersch B., Sprangers B., Rutgeers O., Lenaerts C., Landuyt W., Waer M., et al. Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a Graft-versus-Autoimmunity effect. Biol Blood Marrow Transplant 13 (2007) 627-637
57. McKendry R.J.R., Huebsch L., and Le Clair B. Progression of rheumatoid arthritis following bone marrow transplantation: a case report with a 13 year follow-up. Arthritis Rheum 39 (1996) 1246-1253
58. Tapprich C., Feuk R.R., Schneider P., Bernhardt A., Haas R., Kobbe G., et al. Early recurrence of rheumatoid arthritis after non myeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma. Bone Marrow Transplant 32 (2003) 629-631
59. Marmont A.M., Gualandi F., Occhini D., Morandi F., Ferretti E., Pezzolo A., et al. Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal haemolytic-uremic syndrome. Autoimmunity 39 (2006) 505-511
60. Hoyer B.E., Manz R.A., Radbruch A., and Hiepe F. Long-lived plasma cells and their contribution to autoimmunity. Ann NY Acad Sci 1050 (2005) 124-133
61. Flynn C.M., and Kaufman D.S. Donor cell leukaemia: insight into cancer stem cells and the stem cell niche. Blood 109 (2007) 2688-2692
62. McCann S., and Wright E. Donor leukaemia: perhaps a more common event than we thought!. Bone Marrow Transplant 32 (2003) 455-457
63. Hertenstein B., Hambach L., Bacigalupo A., Schmitz N., McCann S., Sjavin S., et al. Development of leukemia in donor cells after allogeneic stem cell transplantation - a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 90 (2005) 969-975
64. Marmont A.M. Allogeneic haematopoietic stem cell transplantation for severe autoimmune diseases: great expectations but controversial evidence. Bone Marrow Transplant 38 (2006) 1-4
65. McColl G., Koshaka H., and Wicks I. High-dose chemotherapy and syngeneic hemopoietic stem cell transplantation for severe seronegative rheumatoid arthritis. Ann Intern Med 131 (1999) 550-553
66. van Oosterhout M., Verburg R.J., Levahrt E.W., Moolenburgh J.D., Barge R.M., Fibbe W.E., et al. High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host antibodies and synovial abnormalities. Ann Rheum Dis 64 (2005) 1783-1785
67. Zaydan M.A., Turner C., and Miller A.M. Resolution of chronic idiopathic thrombocytopenia purpura following syngeneic peripheral blood transplant. Bone Marrow Transplant 29 (2002) 87-89
68. Alderuccio F., Murphy K., and Toh B.H. Stem cells engineered to express self-antigen to treat autoimmunity. Trends Immunol 24 (2003) 176-180
69. Siatkas C., Chan J., Field J., Murphy K., Nasa Z., Toh B.-H., et al. Gene therapy strategies towards immune tolerance to treat the autoimmune diseases. Curr Gene Ther 6 (2006) 645-658
70. Illei G.G. Hematopoietic stem cell transplantation in autoimmune diseases: is the glass half full or half empty?. Arthritis Rheum 54 (2006) 3730-3734
71. Block S.R. A brief history of twins. Lupus 15 (2006) 61-64
72. Loh Y., Oyama Y., Statkute L., Verda L., Quigley K., Yaung K., et al. Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft versus-autoimmunity without graft-versus-host disease?. Bone Marrow Transplant 39 (2007) 435-437
73. Abraham N., Li M., Vanella L., Peterson S., Ikehara S., and Asprinio D. Bone marrow stem cell transplant into intra-bone cavity prevent Type 2 diabetes: role of heme oxygenase-adiponectin. J Autoimmun 30 (2008) 128-135
74. Boren EJ., Cheema GS., Naguwa SM., Ansari AA., and Gershwin ME. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun 30 1-2 (2007) 90-98
75. Burt R., Craig R., Cohen B., Suffit R., and Barr W. Hematopoietic stem cell transplantation for autoimmune diseases: What have we learned?. J Autoimmun 30 (2008) 116-120
76. Deane S., Meyers F., and Gershwin M. On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years. J Autoimmun 30 (2008) 180-196
77. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmun 30 (2008) 105-107
78. Hara M., Murakami T., and Kobayashi E. In vivo bioimaging using photogenic rats: fate of injected bone marrow-derived mesenchymal stromal cells. J Autoimmun 30 (2008) 163-171
79. Ikehara S. Innovative BMT method for intractable diseases. Immunol Res 38 1-3 (2007) 251-260
80. Ozawa K., Sato K., Oh I., Ozaki K., Uchibori R., Obara Y., et al. Cell and gene therapy using mesenchymal stem cells (MSCs). J Autoimmun 30 (2008) 121-127
81. Ratajczak M.Z., Zuba-Surma E.K., Wysoczynski M., Wan W., Ratajczak J., Wojakowski W., et al. Hunt for pluripotent stem cell - regenerative medicine search for almighty cell. J Autoimmun 30 (2008) 151-162
82. Rezvani A., and Storb R. Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation. J Autoimmun 30 (2008) 172-179
83. Sonoda Y. Immunophenotype and functional characteristics of human primitive CD34-negative hematopoietic stem cells: the significance of the intra-bone marrow injection. J Autoimmun 30 (2008) 136-144